alternative models of gene-environment interaction during cancer initiation

• Date :
• 2    
  0

Current Therapies and Their Indications for the Philadelphia-Negative Myeloproliferative Neoplasms

• Date :
• 2    
  0

Emerging Role for Novel Immunotherapy Agents in Metastatic Renal Cell Carcinoma: From Bench to Bedside

• Date :
• 2    
  0

From Philadelphia-Negative to JAK2-Positive: Effect of Genetic Discovery on Risk Stratification and Management

• Date :
• 2    
  0

Salvage Therapy in Patients with Germ Cell Tumors

• Date :
• 2    
  0

Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma

• Date :
• 2    
  0

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults: A Broader Range of Options, Improved Outcomes, and More Therapeutic Dilemmas

• Date :
• 2    
  0

Addressing Barriers to Uptake of Breast Cancer Chemoprevention for Patients and Providers

• Date :
• 1    
  0

Updates in therapy and clinical trials for other histologies

• Date :
• 1    
  0

don't break the bones

• Date :
• 1    
  0

measuring quality in oncology: an imperative

• Date :
• 1    
  0

pain and substance use disorders

• Date :
• 1    
  0

molecular subtype of diffuse large B-cell lymphoma: ready for the clinic ?

• Date :
• 1    
  0

Challenging the Treatment Paradigm for Advanced Renal Cell Carcinoma: A Review of Systemic and Localized Therapies

• Date :
• 1    
  0

Chemotherapy for Bone Sarcomas in Adults: The MD Anderson Experience

• Date :
• 1    
  0

Clinical Oncology Practice 2015: Preparing for the Future

• Date :
• 1    
  0

Clonal Evolution Models of Tumor Heterogeneity

• Date :
• 1    
  0

Combating Acquired Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

• Date :
• 1    
  0

Current and Future Care of Patients with the Cancer Anorexia-Cachexia Syndrome

• Date :
• 1    
  0

Decision Making in the Context of Breast Cancer Chemoprevention: Patient Perceptions and the Meaning of Risk

• Date :
• 1    
  0

Diagnosing and Managing Advanced Chronic Myeloid Leukemia

• Date :
• 1    
  0

Early Detection of Cancer: Past, Present, and Future

• Date :
• 1    
  0

Endocrine Therapy and Its Effect on Sexual Function

• Date :
• 1    
  0

Epithelial Ovarian Cancer in Older Women: Defining the Best Management Approach

• Date :
• 1    
  0

Evolving Immunotherapy Strategies in Urothelial Cancer

• Date :
• 1    
  0

Germ Cell Tumors: Looking to the Future

• Date :
• 1    
  0

Medical Education: Perils and Progress in Educating and Assessing a New Generation of Learners

• Date :
• 1    
  0

Neoadjuvant Therapy for Melanoma: A Promising Therapeutic Approach and an Ideal Platform in Drug Development

• Date :
• 1    
  0

New and Promising Strategies in the Management of Bladder Cancer

• Date :
• 1    
  0

Precision Medicine for Metastatic Breast Cancer

• Date :
• 1    
  0

Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist

• Date :
• 1    
  0

Surgery or Ablative Radiotherapy for Breast Cancer Oligometastases

• Date :
• 1    
  0

Systemic Therapy for Osteosarcoma and Ewing Sarcoma

• Date :
• 1    
  0

Systemic Treatment: Maintenance Compared with Holiday

• Date :
• 1    
  0

The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase

• Date :
• 1    
  0

The Challenges of Managing Older Patients with Acute Lymphoblastic Leukemia

• Date :
• 1    
  0

The Global Conduct of Cancer Clinical Trials: Challenges and Opportunities

• Date :
• 1    
  0

The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling

• Date :
• 1    
  0

The Role of Surveillance versus Adjuvant Treatment in Stage I Germ Cell Tumors: Outcomes and Challenges

• Date :
• 1    
  0

Treatment of Peritoneal Carcinomatosis of Colorectal Origin

• Date :
• 1    
  0

Triple-Negative Breast Cancer: Molecular Subtypes and New Targets for Therapy

• Date :
• 1    
  0

What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience ?

• Date :
• 1    
  0

ICD-10: a brief history

• Date :
• 0    
  0

molecular subtype specific therapy of diffuse large B-cell lymphoma: are we ready to change the practice ?

• Date :
• 0    
  0

targeting the BRAF-wildtype patient

• Date :
• 0    
  0

is there a role for adjuvant chemotherapy for resected STS?

• Date :
• 0    
  0

Adjuvant Radiation for Soft Tissue Sarcomas

• Date :
• 0    
  0

Application of Molecular Biology to Individualize Therapy for Patients with Liposarcoma

• Date :
• 0    
  0

Advances in Website Information Resources to Aid in Clinical Practice

• Date :
• 0    
  0

Translating survivorship research into health surveillance guidelines

• Date :
• 0    
  0

Assuring Quality Cancer Survivorship Care: We've Only Just Begun

• Date :
• 0    
  0

Beyond Second-Line Therapy

• Date :
• 0    
  0

When to add biologicals in colorectal cancer

• Date :
• 0    
  0

Challenges in drug development for meningiomas

• Date :
• 0    
  0

CD19 CAR Therapy for Acute Lymphoblastic Leukemia

• Date :
• 0    
  0

Can correct diet and exercise choices prevent cancer ?

• Date :
• 0    
  0

Challenges to Standardizing the Care for Adult Cancer Survivors: Highlighting ASCO's Fatigue and Anxiety and Depression Guidelines

• Date :
• 0    
  0

Chemotherapy for Patients with BRCA1 and BRCA2, mutated Ovarian Cancer: Same or Different

• Date :
• 0    
  0

Chemotherapy-Induced Peripheral Neurotoxicity in Cancer Survivors: An Underdiagnosed Clinical Entity

• Date :
• 0    
  0

Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer

• Date :
• 0    
  0

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer Medicine

• Date :
• 0    
  0

Comparative Effectiveness Research in Cancer with Observational Data

• Date :
• 0    
  0

Current Standards and Clinical Trials in Systemic Therapy for Stage III Lung Cancer: What Is New ?

• Date :
• 0    
  0

Expectations in the Care of Lung Cancer

• Date :
• 0    
  0

Geriatric Oncology and Clinical Trials

• Date :
• 0    
  0

Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

• Date :
• 0    
  0

Hepatocellular Carcinoma Tumor Board: Making Sense of the Technologies

• Date :
• 0    
  0

Immunotherapeutic Approaches in Prostate Cancer: Combinations and Clinical Integration

• Date :
• 0    
  0

Improving Clinical Trial Efficiency: Thinking outside the Box

• Date :
• 0    
  0

Locally Advanced Rectal Cancer: Time for Precision Therapeutics

• Date :
• 0    
  0

Making Sense of Current and Emerging Therapies in Pancreatic Cancer: Balancing Benefit and Value

• Date :
• 0    
  0

Management of Chronic Lymphocytic Leukemia

• Date :
• 0    
  0

Management of Older Women with Early-Stage Breast Cancer

• Date :
• 0    
  0

Managing Immune Checkpoint-Blocking Antibody Side Effects

• Date :
• 0    
  0

Merkel Cell Carcinoma: Emerging Biology, Current Approaches, and Future Directions

• Date :
• 0    
  0

Metabolism and Oxidative Stress Response Pathways in Kidney Cancer: A Tale of Chance and Necessity

• Date :
• 0    
  0

Multiple Myeloma: From Front-Line to Relapsed Therapies

• Date :
• 0    
  0

Multiple Myeloma: Is It Time for Biomarker-Driven Therapy ?

• Date :
• 0    
  0

Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms: An Update on Risk Stratification, Molecular Genetics, and Therapeutic Approaches Including Allogeneic Hematopoietic Stem Cell Transplantation

• Date :
• 0    
  0

Neoadjuvant Therapy for Breast Cancer: Controversies in Clinical Trial Design and Standard of Care

• Date :
• 0    
  0

Neoadjuvant and Adjuvant Therapy for HER2 Positive Disease

• Date :
• 0    
  0

New Targeted Therapies for Indolent B-Cell Malignancies in Older Patients

• Date :
• 0    
  0

Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond

• Date :
• 0    
  0

Novel Agents in the Therapy of Hodgkin Lymphoma

• Date :
• 0    
  0

Novel Treatments for T-Cell Lymphoma

• Date :
• 0    
  0

Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer

• Date :
• 0    
  0

Perfusion and Infusion for Melanoma In-Transit Metastases in the Era of Effective Systemic Therapy

• Date :
• 0    
  0

Prognostic Factors and the Role of Adjuvant Radiation Therapy in Non-Melanoma Skin Cancer of the Head and Neck

• Date :
• 0    
  0

Radium 223: How Can We Optimize This New Tool for Metastatic Castration-Resistant Prostate Cancer ?

• Date :
• 0    
  0

Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015

• Date :
• 0    
  0

Resistance to Anti-HER2 Therapies in Breast Cancer

• Date :
• 0    
  0

Sexual Healing in Patients with Prostate Cancer on Hormone Therapy

• Date :
• 0    
  0

Smoldering Multiple Myeloma: When to Observe and When to Treat

• Date :
• 0    
  0

State of the Art Discovery with Tumor Profiling in Pediatric Oncology

• Date :
• 0    
  0

Targeted and Immunotherapeutic Approaches in Brain Metastases

• Date :
• 0    
  0

The Impact of Industry on Oncology Research and Practice

• Date :
• 0    
  0

The Past, Present, and Future of Patient-Reported Outcomes in Oncology

• Date :
• 0    
  0

The Patient-Centered Medical Home in Oncology: From Concept to Reality

• Date :
• 0    
  0

The Spectrum of Neuroendocrine Tumors: Histologic Classification, Unique Features and Areas of Overlap

• Date :
• 0    
  0

The Value of Lung Cancer CT Screening: It Is All about Implementation

• Date :
• 0    
  0

Treating Older Adults with Cancer: Geriatric Perspectives

• Date :
• 0    
  0

Triple-Negative Breast Cancer: Immune Modulation as the New Treatment Paradigm

• Date :
• 0    
  0

Using Social Media to Learn and Communicate: It Is Not About the Tweet

• Date :
• 0    
  0

Why Chemotherapy Should be Given Early for Men with Metastatic Prostate Cancer

• Date :
• 0    
  0

Congrès ESMO 2026

• Date :
• 805    
  0

Congrès ESMO d'Immuno-Oncologie 2025

• Date :
• 1319    
  0

SABCS 2025 Symposium

• Date :
• 7716    
  0

Congrès ESMO Asie 2025

• Date :
• 951    
  0

17ᵉ Congrès Européen Multidisciplinaire sur le Cancer Urologique - EMUC25

• Date :
• 1417    
  0